Search Drug Information, Interactions, Images, Dosage & Side Effects

Child abuse increased during COVID-19 lockdown 30 Nov 2021

Child abuse rates appear to have increased during the lockdowns imposed to control COVID-19 transmission, according to a study from the US presented at the 2021 American Academy of Pediatrics National Conference & Exhibition (AAP 2021).

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

30 Nov 2021

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

30 Nov 2021

Childhood cancers often misdiagnosed as TB, leads to more deaths

30 Nov 2021

New chest pain guideline: Takeaways & Concerns 30 Nov 2021
A new guideline on chest pain evaluation and diagnosis – touted as the first of its kind – is now out, reaping both praises and dissent from experts.

What is the optimal tanezumab dose, administration route for osteoarthritis pain?

30 Nov 2021

Spontaneous eye blink rate a good marker of consciousness after brain injury

30 Nov 2021

High vegetable and fruit intake improves QoL among Chinese breast cancer patients

30 Nov 2021

New chest pain guideline: Takeaways & Concerns

30 Nov 2021

What is the optimal tanezumab dose, administration route for osteoarthritis pain?

30 Nov 2021

Spontaneous eye blink rate a good marker of consciousness after brain injury

30 Nov 2021

High vegetable and fruit intake improves QoL among Chinese breast cancer patients

30 Nov 2021

CONUT, PNI predict technique failure during peritoneal dialysis

29 Nov 2021

Higher sodium, lower potassium urine excretion tied to increased CV risk

29 Nov 2021

Repurposing a broad-spectrum antiviral drug may help treat asymptomatic, mild COVID-19

29 Nov 2021

Remnant cholesterol tied to CVD death in patients with T2D, CKD, diabetic nephropathy

29 Nov 2021

Exercise superior to usual care at reducing upper limb disability after breast cancer surgery

29 Nov 2021

Insulin secretion predicts response to therapy in new-onset diabetes

29 Nov 2021

Add-on ezetimibe helps reduce LDL-C in post-ACS patients

29 Nov 2021

Flucloxa

Contents : Flucloxacillin

Indications/Uses : Infections due to gram-positive organisms including infections caused by β-lactamase-producing Staphylococci; resp tract infections (eg, pneumonia, lung abscess, empyema, sinusitis, pharyngitis, tonsillitis), skin & soft tissue infections (eg, boils, abscesses, carbuncles, furunculosis, infected skin conditions; osteomyelitis, enteritis, endocarditis, UTI, meningitis, septicaemia. Prophylactic agent during major surgical procedures eg, cardiothoracic & orthopedic surgery.

Daflon 1000 mg

Contents : Micronized purified flavonoid fraction 1,000 mg (diosmin 900 mg, hesperidin 100 mg)

Indications/Uses : Symptoms related to venolymphatic insufficiency (heavy legs, pain, restless legs syndrome at bedtime). Functional symptoms related to acute hemorrhoidal attack.

Daflon 1000 mg

Contents : Micronized purified flavonoid fraction 1,000 mg (diosmin 900 mg, hesperidin 100 mg)

Indications/Uses : Symptoms related to venolymphatic insufficiency (heavy legs, pain, restless legs syndrome at bedtime). Functional symptoms related to acute hemorrhoidal attack.

Zimilast

Contents : Imipenem, cilastatin

Indications/Uses : Serious infections caused by susceptible microorganisms in the following conditions: Lower resp tract infection, complicated & uncomplicated UTI, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone & joint infections, skin & skin structure infections, endocarditis, polymicrobic infections.

Perosu

Contents : Rosuvastatin Ca

Indications/Uses : Adjunct to diet when response to diet & other non-pharmacological treatments (eg, exercise, wt reduction) is inadequate in adults, adolescents & childn ≥6 yr w/ primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb). Adjunct to diet & other lipid-lowering treatments (eg, LDL apheresis) or if such treatments are not appropriate in adults, adolescents & childn ≥6 yr w/ homozygous familial hypercholesterolaemia. Decrease elevated total cholesterol (total-C), LDL-cholesterol (LDL-C) & triglycerides (TG) & increase high density lipoprotein cholesterol (HDL-C) in adults w/ primary hypercholesterolemia (heterozygous familial & non-familial) or mixed dyslipidemia (Fredrickson types IIa & IIb). Decrease Apo B, non-HDL-C, VLDL-C, VLDL-TG, LDL-C/HDL-C & Apo B/Apo A-I ratios & increase Apo A-I in adults. Isolated hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Primary dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia). Decrease total-C & LDL-C in patients w/ homozygous familial hypercholesterolaemia as adjunct to other lipid-lowering treatments or alone. Slow progression of atherosclerosis to decrease total-C & LDL-C. Decrease total-C, LDL-C & Apo B levels in childn & adolescents 6-17 yr (boys ≥ Tanner Stage II & girls who are at least 1 yr post-menarche) w/ heterozygous familial hypercholesterolaemia. Decrease risk of stroke, MI & arterial revascularization procedures in individuals w/o clinically evident CHD but w/ increased risk of CV disease.

Sultab

Contents : Sultamicillin

Indications/Uses : Infections caused by susceptible microorganisms eg, upper resp tract infections including sinusitis, otitis media & tonsillitis; lower resp tract infections including bacterial pneumonias & bronchitis; UTIs & pyelonephritis; skin & soft tissue infections; intra-abdominal & gonococcal infections. Patients requiring sulbactam/ampicillin therapy following initial treatment w/ sulbactam/ampicillin IM/IV.

Carivalan

Contents : Per 6.25 mg/5 mg tab carvedilol 6.25 mg, ivabradine 5 mg. Per 6.25 mg/7.5 mg tab carvedilol 6.25 mg, ivabradine 7.5 mg. Per 12.5 mg/5 mg tab carvedilol 12.5 mg, ivabradine 5 mg. Per 12.5 mg/7.5 mg tab carvedilol 12.5 mg, ivabradine 7.5 mg. Per 25 mg/5 mg tab carvedilol 25 mg, ivabradine 5 mg

Indications/Uses : Substitution therapy in adult patients w/ normal sinus rhythm already controlled by ivabradine & carvedilol taken concomitantly at the same dose level for symptomatic chronic stable angina pectoris in CAD patients; chronic heart failure (NYHA class II-IV) w/ systolic dysfunction.

Carivalan

Exulten

Contents : Sertraline HCl

Indications/Uses : Major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder w/ or w/o agoraphobia, post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), social anxiety disorder or phobia in adults. OCD in childn 6-17 yr.

Zisuva 375/Zisuva 625/Zisuva 1G/Zisuva DS

Contents : Co-amoxiclav (amoxicillin & clavulanic acid). Per Zisuva 375 FC tab Amoxicillin 250 mg, clavulanic acid 125 mg. Per Zisuva 625 FC tab Amoxicillin 500 mg, clavulanic acid 125 mg. Per Zisuva 1G FC tab Amoxicillin 875 mg, clavulanic acid 125 mg. Per Zisuva DS powd for oral susp 5 mL Amoxicillin 125 mg, clavulanic acid 31.25 mg

Indications/Uses : Otitis media, sinusitis, infections caused by susceptible organisms involving the lower resp tract, skin & skin structure, & urinary tract w/ additional coverage of β-lactamase producing B. catarrhalis, H. influenzae, N. gonorrhoeae & S. aureus (not MRSA) in patients w/ amoxicillin resistance & those who cannot tolerate alternative treatments.

Oramin-C

Contents : Ascorbic acid (vit C) 500 mg, thiamine nitrate (vit B₁) 50 mg, riboflavin (vit B₂) 20 mg, pyridoxine HCl (vit B₆) 5 mg, Ca pantothenate (vit B₅) 20 mg, nicotinamide (vit B₃) 50 mg, cyanocobalamin 0.1% (vit B₁₂) 5 mcg

Indications/Uses : For body resistance & stress release. Stress relief & health benefits, optimize energy release for improved work performance & boost immune system against various illnesses & diseases.

Zifam Linglip

Contents : Linagliptin

Indications/Uses : Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM as monotherapy or combination therapy w/ metformin, sulphonylurea + metformin or insulin w/ or w/o metformin.

Tascit

Contents : K citrate

Indications/Uses : Renal tubular acidosis (RTA) w/ Ca stones; hypocitraturic Ca oxalate nephrolithiasis of any etiology; uric acid lithiasis w/ or w/o Ca stones. Prevention of stone relapse after extracorporeal shock wave lithotripsy (ESWL) or lithotomy.

New Brand

7 New

pill identifier

Shape

Form

Color 1

Color 2

Markings

Shape

Form

Color 1

Color 2

Search Drug Information, Images & Medical News | MIMS Myanmar

Flucloxa

Daflon 1000 mg

Daflon 1000 mg

Zimilast

Perosu

Sultab

Carivalan

Carivalan

Exulten

Zisuva 375/Zisuva 625/Zisuva 1G/Zisuva DS

Oramin-C

Zifam Linglip

Tascit